Ranbaxy
-
Upload
shivanand09 -
Category
Documents
-
view
680 -
download
0
Transcript of Ranbaxy
Management Trainee
Programme
Agenda
• What we do…
– About Ranbaxy Group
• How we do it…
– Ranbaxy Advantage
• How you fit in...
– The Management Trainee Program
What we do……
An Overview
• Among India’s largest pharmaceutical companies
• Ranbaxy & Daiichi Sankyo combined rank among the top 20 global pharmaceutical
companies
• Worldwide Presence
• Ground presence in 46 countries, products sold in over 125 countries
• Manufacturing locations in 7 countries
• Global consolidated sales – US $ 1519 Mn (2009)
• Highest R&D spender amongst Indian Pharmaceutical companies
• Business
- International 77%
- Domestic 23%
• Around 14000 employees globally represented by 50 nationalities
Where we operate
Ranbaxy – Daiichi Sankyo Partnership
• Significant and sustained operational and strategic synergies
across the globe
– Collaborative marketing opportunities leveraging
Ranbaxy’s substantial footprint
– Manufacturing
– R&D
– Global supply chain
– IT functions
• Combining innovator and generics capabilities, to straddle full
spectrum of pharma value chain
Hybrid
Business
Model
Global Pharma Innovator Global Generics Company
• A path breaking confluence that redefines the global pharma paradigm
• Strategic combination creates an Innovator and Generic Pharmaceutical Powerhouse
Ranbaxy Corporate Office
Our state-of-the-art Head Quarters is located at Gurgaon, New Delhi NCR
The ‘Brain Center’ for all our Global Strategies
Vision, Mission & ValuesMission
• To become a Research-based International Pharmaceutical Company”
Vision 2012
• Achieve significant business in proprietary prescription products by 2012 with a strong presence in developed markets
Values
• Achieving customer satisfaction is fundamental to our business
• Provide products and services of the highest quality
• Practice dignity and equity in relationships and provide opportunities for our people to
realise their full potential
• Ensure profitable growth and enhance wealth of the shareholders
• Foster mutually beneficial relations with all our business partners
• Manage our operations with high concern for safety and environment
• Be a responsible corporate citizen
• Dedicated Facilities for Innovative & Generics Research
• More than 1200 R&D Personnel
• Highest R&D spender amongst Indian Pharmaceutical companies
• NDDS based products (4 platform technologies)
• NDDR - Arterolane + PQP (Anti malaria)
• One program with GSK (Respiratory)
• R&D collaborations with Industry & Academia
Collaboration in Clinical Development of NCE
Research & Development
Research & Development
State-of-the-art R&D facilities based in Gurgaon (India)
R&D I R&D IIIR&D II
R&D IV R&D V R&D VI
Global Manufacturing Strengths
• cGMP compliant world-class API & Dosage Forms manufacturing
facilities across the globe
• 7 manufacturing locations worldwide
• API facilities - increasing vertical integration
• Creating capacities for specialty products
• New facilities added in cost advantageous geographies
Global Manufacturing Strengths
India
USA Ireland NigeriaRomania
South Africa Malaysia
Key Strengths
• Our
innovative
use of
technology
• Confidence
in our
expertise
• Empowerment
&
Independency
• Calculated
risk taking
ability
• The aptitude
of our people
• Our ability
to react
swiftly
• Knowledge
of our
markets
Ranbaxy is the partner of choice
Global Sales Split
* CIS includes Russia & Ukraine belt
US $ 1519 Mn (2009)
All figures in US $
269 Mn 18%
397 Mn 26%
86 Mn6% 441 Mn
29%
214 Mn 14%
112 Mn7%
CIS*
Asia
RoW
APIEurope
North
America
How we do it ...
Global Pharmaceutical Landscape
Global Pharmaceuticals Market:
• 2009: ~ US $ 727 Bn (+5.7%)
Global Generics Market:
• 2009: US $ 83 Bn (+7.7%)
Key Drivers of Generics:
Significant patent expiries (~US
$ 80 Bn drugs) through 2012
• Increasing generic penetration
• Rationalizing healthcare costs
• Emerging markets opportunity
Source : IMS Mat Nov 2009
Global Pharma Market Slice
US $ Bn
316
226
152
80 33
North America Europe
Africa, Asia and Australia Japan
Latin America
Advantage India
India will be the 10th largest pharma market by 2015 with drivers like:
• Epidemic of ‘Lifestyle’ illnesses
• Medical Infrastructure, Affordability & Healthcare Reach
• India is the Global Pharma Outsourcing Hub
• Enhanced clinical research capabilities
• Large talent pool
• Treatment Naïve patients
• High quality standards for trials
• Strong manufacturing backgrounds
• Largest # of US FDA approved plants outside the US 61 plants
• Large pool of API & Finished Dose formulation
• manufacturing facilities
• India is 3rd largest API manufacturer with USD 2 Bn
• 40% of US DMF filings from India
• Low cost & high quality of manufacturing
Source: IMS Health: MIDAS, MAT Dec 2006 & IMS World Review; Analyst projections;
McKinsey India Pharmaceutical Demand Model, India – Includes institutional sales
GROWTH IN THE DOMESTIC MARKET & STRONG INDUSTRY FUNDAMENTALS
The Global Generics Advantages
Consolidation
Growth Potential
• Size & Scale
• Therapeutic Width
• Operational Synergies
• Pressure on Vanilla Gx
• Move to Specialty/ Niche
Product Portfolio
• Patent Expiries
• New Markets
• Healthcare Costs
India Factor
• Scientific Talent
• Cost Advantage
• Gx / Rx
• Competencies
Ranbaxy Business Model
Global Reach Product
Portfolio
Research &
DevelopmentManufacturing
Developed Markets
North America, EU,
Japan, Australia
Emerging markets
India Romania, CIS
South Africa, Brazil
Mexico
• Generics,
• Branded Generics
• OTC
• Generics/NDDS*
• Complex/Niche/FTF*
• Select New Chemical
Entities
• Dosage Form
• API * - Vertical Integration
• In-house/Outsource
* NDDS – Novel Drug Delivery System, API – Active Pharmaceutical Ingredients, FTF – First to File
Competitive Advantage @ Ranbaxy
Competetive cost, innovative and high quality product flow
Manufacturing
Efficiencies
Aggressive
Marketing
R&D
Capabilities
Highly competitive
domestic market
Labor
Infrastructure
Global Quality Standards
Skilled Scientist Pool
- Generics
- Innovative Research
Process Chemistry
Expertise
Global Head Quarter INDIA
o Among India’s largest pharmaceutical companies
o One of the largest distribution networks that comprises over 4000
field force
o Dedicated task forces for specialized & chronic therapies
o 18 brands in Top 300 of Industry
o Project ‘Viraat’ – A key initiative to strengthen company’s
domestic leadership position
Developed Market Presence
• Largest generic market worldwide
• Significant patent expiries through 2012
• Mature generic market
• Ranbaxy is the fastest growing generics company in Canada
USA
Canada
EU
Japan
• Germany, UK - mature markets
• France, Spain, Italy, Romania - emerging markets
• Ranbaxy has presence in 23 of the 27 EU countries
• Emerging generic market, < 5% generic penetration
• 1st Indian pharma company
Emerging Markets Presence
• Among India’s largest pharmaceutical companies
• Growing at a fast pace
• Ranked as the No. 1 Generics Company
• Strategic for servicing EU operations
• Strong base in acute therapies
• Fast expanding into chronic and OTC segments
• Key market in the African continent
• A strong No. 5 player in the region
India
Romania
Russia &
Ukraine
South Africa
To capitalize on the opportunities in the ongoing consolidation for…
... providing a strategic and value accretive fit
Inorganic Strategy
• Size and scale in developed & emerging markets
• Expansion of geographical reach
• Access to niche and complex products / therapeutic areas
• Costs efficiencies in manufacturing and R&D
Key Acquisitions & Alliances
INDIA
* Zenotech
* Cardinal Drugs
* Ochoa Labs
* Biovel
OTHER COUNTRIES
* Terapia (Romania)
* Be-Tabs(South Africa)
* Allen (Italy)
* Mundogen (Spain)
More than US $ 500 Mn spend on M&A
$
Corporate Social Responsibility
Ranbaxy Community Healthcare Services founded in 1979
Covering areas of :
* Maternal Child Health
* Family Planning
* Reproductive Health
* Adolescent Health
* Health Education
* AIDS awareness
* Preventive
* Promotive
* Curative Services
It has an integrated approach
Corporate Social Responsibility
• Corporate Social Responsibility is inscribed in our VALUES
• Ranbaxy Rural Development Trust set up in 1978 (later re-christened
as ‘Ranbaxy Community Health Care Society’)
• We serve about 2 lakh people staying in 110 villages and urban slum
areas; of Punjab, Haryana, Himachal Pradesh, Madhya Pradesh
• Launched Mobile Healthcare services : infrastructure includes 14
Mobile Health Care Vans
• Public Private Partnership (PPP) with the Punjab State Government, to
deliver healthcare services in identified districts of Punjab. The program
- Ranbaxy Sanjeevan Swasthya Seva - is being rolled out in a phased
manner
• Partnered with State & Central Government of India in critical areas
HIV/AIDS, tuberculosis, Malaria, Polio, non-communicable chronic
diseases and female foeticide.
Management Trainee Programme
Multifaceted Interaction
Corporate HR
Conducts/ facilitates
Management Trainee
programme. Acts as
sounding board
Cross Functional Team &
Steering Committee
(All Mentors)
Coach Trainees, removes
Roadblocks, conducts
assessments,
Finalizes placements and set
Direction for the program.
Business/Functional
Head
Acts as guide –
Agrees projects with
his/her team & is
responsible for
direction, support &
assessment
Management
Trainees –
Accountable for
learning & delivery
MTP @ Ranbaxy
Purpose
The purpose of theprogramme is to helpthe MT to experiencethe various facets ofRanbaxy and therebyprepare for theassigned role
Process
The programme focuses predominantly onexperiential learning through on the jobprogrammes. This is achieved through
Basic understanding of the business throughlectures and interactive sessions
Project work in various areas of the keyfunction, across different locations
Self-awareness sessions Self development with training on key
behavioral attributes
The Programme
Total Duration of MT: 12 months with 3 Rotations
First 15 days
InductionInduction provided by Corporate HR
Project Assignment 1Project provided by respective assigned department
Project Assignment 2 & 3Project suggested by respective department but in different locations
Next 3 and a
half months
Last 8 months
Informal Review of Progress
Review of Progress by Coach/Manager
Review of Progress at the end of 12 months
Objective:-Induction helps MT to
know about Ranbaxy as an organization, its culture, values, ethics and company vision & mission
Objective:-Provide platform for
the MT to get familiarized with the functioning of assigned area of interest & accelerate learning curve
Objective:-Provide an in-depth
understanding of the function at different locations
First 18 months
Suggested Career Ladder - Illustrative
International Assignment
Cross Functional Exposure
Continuous Development Opportunity
Competitive Pay Packages
Diversity
A B C DD
Job Class Progression
E
Some of Our Graduate Top Achievers...
NameCurrent
DesignationFunction Area Batch Institute Name
Neeraj KukretiDirector - Business
Solutions
Business Solutions
Group1995 FMS
Sandeep Juneja Director - M&ACorporate
Development1994 IIFT
Anupam Bhatt Director - HRPharma
Manufacturing1990 XISS
K. Venkatachalam Sr. VP & RD Ranbaxy Inc. (USA) 1993 SPJ
Abhimanyu OjhaGM-Global Hybrid
Business
Global Hybrid
Business2002 IMI
Hemant DhondgeGM-Production
PlanningGlobal Supply Chain 1993
Sydenham Institute of
Bombay University
Karan KhambatiProduct Manger -
UkraineCIS 2006 NMIMS
Poonam Bharti GM-HR R&D 1995 TISS
Ravi Natarajan GM-MaterialsGlobal Material
Sourcing1990
Symbiosis Institute –
Poona University
Selection Process
Recruitment through campus selection process in business
Schools
CVs short listed as per the predefined parameters
Group Discussion
Personal Interview
Psychometric Test for short listed candidates
What we offer
• Earning Potential (CTC) up to Rs. 9,58,660 annual
• Performance driven career growth
• Growth through Continuous Learning
• Opportunity of working with a Global Pharma Major in the fast paced Pharma market
• One Time Relocation Expenses: Rs. 25,000/-
• Fixed Total
• Includes Stipend, Subsidies – House
Rent, Conveyance, Education, Utility, Medical, Leave Travel, Bonus, Telephone, Hard
Furnishing, Retirals
• Variable pay
• Other Benefits
• Group Hospital Insurance around Rs. 1.20 lac per annum for per declared dependent
(immediate family)
• Group Term Insurance – Varies (based on eventuality) – up to maximum of Rs. 9.50 lac
Salary
Details
Questions
Step 1: Read more about the organisation from official website www.ranbaxy.com
Step 2: All the candidates have to go through the entire selection process and final selection
will be the sole discretion of the organisation.
Step 3: Dates for campus recruitment will be communicated to the Placement Coordinator
Step 4: For any query please route through your respective Placement Coordinator
Step 5: Offer will be treated final only after receiving written confirmation from the
organization
Step 6: The offer of appointment is subject to your successful completion of company’s
medical examination and verification of your testimonials/certificates
Step 7: One year training will start from June 1, 2011
Step 8: For any clarification related to MT Programme, Training, joining and other related
matters please contact at [email protected]
Next Steps
Disclaimer
• This presentation includes forward-looking statements. Such statements are only
predictions and actual events or results may differ materially. For a discussion of
important factors which could cause actual results to differ from the forward-looking
statements, please refer to Ranbaxy Laboratories Limited Annual Report and
Accounts
• Nothing in this presentation constitutes or shall be taken to constitute an offer,
invitation or inducement to any person to invest in Ranbaxy and no reliance should
be placed on the information contained in it in connection with any investment
decision or for any other reason. Ranbaxy Laboratories Limited and its affiliates do
not make any representation or warranty, express or implied, with respect to the
completeness, adequacy or accuracy of the information contained in this
presentation
THANK YOU